Kate Tisdale is a biomedical researcher driven by a fascination with hematopoiesis and the origins of blood cancers like leukemia. She earned her B.A. in Biology from Meredith College, graduating summa cum laude. She continued her training with an M.S. in Biology from the University of North Carolina, where her research focused on the genetic underpinnings of infant leukemia.
Tisdale’s scientific interests center on identifying the molecular factors that drive hematological disorders. She has studied compounds capable of inducing the chromosomal translocations that initiate leukemia and is particularly intrigued by the mechanisms that allow malignant cells to hijack normal hematopoietic pathways. As a participant in the 2024 Pediatric Oncology Education (POE) Program at St. Jude, Tisdale worked in the McKinney-Freeman Lab to explore the binding partners of GPRASP2, a novel regulator of hematopoietic stem cell transplants.
Beyond the bench, Tisdale developed a strong passion for mentorship while working as a teaching assistant during her master’s studies. This experience reinforced her love of science and her desire to help others discover their own path in research.
Tisdale chose the St. Jude Graduate School for its mission-driven culture, cutting-edge science, and deeply supportive environment. She looks forward to continuing her development as an independent scientist while contributing to discoveries that improve outcomes for children with catastrophic diseases.
Hometown: Charlotte, NC
Education:
2025 - MS, Biology – University of North Carolina
2021 - BA, Biology – Meredith College
Awards/Honors/Scholarships:
2021 - Summa Cum Laude – Meredith College
2019 - Outstanding Rising Junior in Biology – Meredith College